Regenxbio
RGNX
172 hedge funds and large institutions have $1.3B invested in Regenxbio in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 71 increasing their positions, 53 reducing their positions, and 25 closing their positions.
358% more call options, than puts
Call options by funds: $14.2M | Put options by funds: $3.1M
34% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 53
16% more capital invested
Capital invested by funds: $1.12B → $1.3B (+$180M)
1.51% more ownership
Funds ownership: 77.3% → 78.81% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
7% less funds holding
Funds holding: 184 → 172 (-12)
48% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$48M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$8.41M |
| 3 |
JP Morgan Chase
New York
|
+$7.9M |
| 4 |
Morgan Stanley
New York
|
+$7.31M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$26.6M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$7.23M |
| 3 |
BlackRock
New York
|
-$3.68M |
| 4 |
Two Sigma Investments
New York
|
-$3.58M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3.43M |
RGNX Hedge Fund Activity: Q2 2021 in Review
172 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q2 2021, worth a combined $1.3B — up 16% from $1.12B a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of RGNX and 13 opened new positions — a net loss of 12 holders — while 53 trimmed existing stakes and 71 added.
The largest buyer was RTW Investments, adding an estimated $48M. The largest seller was Point72 Asset Management, cutting an estimated $26.6M.
- 172 institutional investors held Regenxbio (RGNX) as of Q2 2021, down from 184 in Q1 2021.
- Funds reported $1.3B of Regenxbio stock for Q2 2021, up 16% quarter-over-quarter.
- 13 funds opened new Regenxbio positions in Q2 2021 and 25 closed out, a net change of -12 holders.
- The largest Regenxbio buyer in Q2 2021 was RTW Investments, an estimated $48M added.
- The largest Regenxbio seller in Q2 2021 was Point72 Asset Management, an estimated $26.6M sold.
Based on aggregated 13F filings for Q2 2021.